Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Normann

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Psychotherapy and Psychosomatics|December 31, 2014
Overcoming treatment resistance in chronic depression: a pilot study on outcome and feasibility of the cognitive behavioral analysis system of psychotherapy as an inpatient treatment programEva-Lotta Brakemeier, Martina Radtke, Vera Engel, et al.
International Journal of Molecular Sciences|August 10, 2024
Anti-Neuroinflammatory Effects of <i>Ginkgo biloba</i> Extract EGb 761 in LPS-Activated BV2 Microglial CellsLu Sun, Matthias Apweiler, Ashwini Tirkey, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Anti-Inflammatory Effects of GPR55 Agonists and Antagonists in LPS-Treated BV2 Microglial CellsLu Sun, Matthias Apweiler, Claus Normann, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|October 5, 2018
[CBASP as an Inpatient Concept for Treatment-Resistant Chronic Depression: A Pilot Study of the Relationship between Adverse Effects and Treatment Outcome]Eva-Lotta Brakemeier, Philipp Herzog, Martina Radtke, et al.
Translational Psychiatry|October 20, 2025
Development of VEP-based biomarkers to assess plasticity statesViktoria Galuba, Theresa Wolf, Anouk Ihle, et al.
Neuroimage|July 13, 2026
Visual Cortical Plasticity Depends on Stimulus Structure and Temporal DynamicsViktoria Galuba, Theresa Wolf, Lena Harbig, et al.
Plos One|July 22, 2021
Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disordersJan Wolff, Pamela Reißner, Gudrun Hefner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 10, 2016
State-Dependent Partial Occlusion of Cortical LTP-Like Plasticity in Major DepressionMarion Kuhn, Florian Mainberger, Bernd Feige, et al.
Molecules (Basel, Switzerland)|June 13, 2025
Isomeric 3-Pyridinylmethylcoumarins Differ in Erk1/2-Inhibition and Modulation of BV2 Microglia-Mediated NeuroinflammationRami Schulzki, Matthias Apweiler, Caroline Röttger, et al.
Psychotherapy and Psychosomatics|May 30, 2015
Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Chronic Major DepressionElisabeth Schramm, Ingo Zobel, Dieter Schoepf, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Psychotherapy and Psychosomatics|December 31, 2014
Overcoming treatment resistance in chronic depression: a pilot study on outcome and feasibility of the cognitive behavioral analysis system of psychotherapy as an inpatient treatment programEva-Lotta Brakemeier, Martina Radtke, Vera Engel, et al.
International Journal of Molecular Sciences|August 10, 2024
Anti-Neuroinflammatory Effects of <i>Ginkgo biloba</i> Extract EGb 761 in LPS-Activated BV2 Microglial CellsLu Sun, Matthias Apweiler, Ashwini Tirkey, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Anti-Inflammatory Effects of GPR55 Agonists and Antagonists in LPS-Treated BV2 Microglial CellsLu Sun, Matthias Apweiler, Claus Normann, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|October 5, 2018
[CBASP as an Inpatient Concept for Treatment-Resistant Chronic Depression: A Pilot Study of the Relationship between Adverse Effects and Treatment Outcome]Eva-Lotta Brakemeier, Philipp Herzog, Martina Radtke, et al.
Translational Psychiatry|October 20, 2025
Development of VEP-based biomarkers to assess plasticity statesViktoria Galuba, Theresa Wolf, Anouk Ihle, et al.
Neuroimage|July 13, 2026
Visual Cortical Plasticity Depends on Stimulus Structure and Temporal DynamicsViktoria Galuba, Theresa Wolf, Lena Harbig, et al.
Plos One|July 22, 2021
Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disordersJan Wolff, Pamela Reißner, Gudrun Hefner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 10, 2016
State-Dependent Partial Occlusion of Cortical LTP-Like Plasticity in Major DepressionMarion Kuhn, Florian Mainberger, Bernd Feige, et al.
Molecules (Basel, Switzerland)|June 13, 2025
Isomeric 3-Pyridinylmethylcoumarins Differ in Erk1/2-Inhibition and Modulation of BV2 Microglia-Mediated NeuroinflammationRami Schulzki, Matthias Apweiler, Caroline Röttger, et al.
Psychotherapy and Psychosomatics|May 30, 2015
Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Chronic Major DepressionElisabeth Schramm, Ingo Zobel, Dieter Schoepf, et al.
Pageof 10